Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Effectiveness

SG Sarah D. Gilman
PG Patti E. Gravitt
VP Valerie A. Paz-Soldán
ask Ask a question
Favorite

Effectiveness was evaluated by tracking data on the proportion of women who completed the CCSM continuum of care, comparing the proportion of Pap/VIA screen-positive women who attended colposcopy with the proportion of HPV screen-positive women receiving thermoablative treatment for management of pre-cancerous lesions, or referral to colposcopy (based on documentation that women received colposcopy) if ineligible for ablation. Additionally, semi-structured interviews were conducted with multilevel stakeholders at varying time points pre- and post-implementation (see Fig. 6) due to the fluidity and complexity of this system change: as challenges were identified, the research team collected data to understand the problem. For example, interviews were conducted with women who were lost to follow-up before and after implementation of the new approach to understand barriers in the system, as well as the potential role of stigma in generating barriers to seeking screening or care.

Copyright and License information: The Author(s) ©2024
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A